Radient Pharmaceuticals Corp (RPC) announced broad availability of its 2010 Onko-Sure® Reference Guide for the Company’s USFDA-approved Onko-Sure® in vitro diagnostic (IVD) cancer test kit.
The 2010 Onko-Sure® Reference Guide is a commercially published compilation of Radient Pharmaceuticals general information and clinical studies on the Company’s Onko-Sure® IVD cancer test kit. Designed to provide oncologists, physicians and clinicians with the most current and important information for Onko-Sure®, the guide also serves as a comprehensive reference for other health care professionals, consumers and patients.
In addition to general Company information and Onko-Sure® clinical study data, RPC’s 2010 Onko-Sure® Reference Guide provides a comprehensive list of key references, resources and other published materials users can consult to better understand the medical utilities of Onko-Sure®, how healthcare providers and patients can use the test and the science behind Onko-Sure®.
RPC’s Onko-Sure® IVD cancer test is a simple, non-invasive, patent-pending and regulatory-approved in vitro diagnostic (IVD) test used for the detection, screening, and monitoring of various types of cancer. The test enables physicians and healthcare professionals to effectively monitor and/or detect certain types of cancers by measuring the accumulation of Fibrin and Fibrinogen Degradation Products (FDP) in the blood. FDP levels rise dramatically with the progression of cancer. Onko-Sure® is approved by the US FDA for the monitoring of colorectal cancer and by Health Canada as a lung cancer detection and monitoring test.
According to Douglas MacLellan, Chairman and CEO of Radient Pharmaceuticals, "The 2010 Onko-Sure® Reference Guide is an invaluable resource for both members of the healthcare community and patients alike, and we believe it will serve as an important educational tool that will drive broad-based adoption and use of RPC’s Onko-Sure® IVD cancer test for the diagnosis, treatment and monitoring of cancer."
Source: Radient Pharmaceuticals Corp